[Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003]

Insights

Streptococcus pneumoniae resistance to antibiotics fluctuated between 1998-2003 in Moscow, potentially linked to antibiotic usage. By 2003, resistance to penicillin and erythromycin was notable, while fluoroquinolone resistance remained low.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic resistance in Streptococcus pneumoniae is a significant global health concern.
  • Understanding local resistance patterns is crucial for effective treatment strategies.

Purpose of the Study:

  • To analyze the trends in Streptococcus pneumoniae resistance to various antibiotics in Moscow from 1998 to 2003.
  • To investigate the potential correlation between antibiotic usage and resistance emergence.

Main Methods:

  • Longitudinal observational study over a 6-year period (1998-2003).
  • Monitoring of Streptococcus pneumoniae isolates for antimicrobial resistance.
  • Correlation analysis with antibiotic consumption data (inferred).

Main Results:

  • A decrease in resistance was observed in 2000-2001, followed by an increase.
  • In 2003, resistance rates were 18.6% for penicillin, 19% for erythromycin, and high for tetracycline (40.1%) and co-trimoxazole (29.1%).
  • Low resistance rates were noted for amoxicillin (0.4%), cefotaxime (2.1%), levofloxacin, and moxifloxacin.

Conclusions:

  • Antibiotic resistance dynamics in Streptococcus pneumoniae are complex and influenced by usage patterns.
  • Sustained surveillance and judicious antibiotic use are essential to mitigate rising resistance.
  • Fluoroquinolones remained effective against most strains during the study period.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview